Bacteremia Due to Viridans Streptococci That Are Highly Resistant to Penicillin: Increase Among Neutropenic Patients with Cancer
We prospectively studied 260 episodes of bacteremia that occurred over a 6-year period in neutropenic patients with cancer. Twenty-three episodes were caused by viridans streptococci. Thirteen (57%) of these strains were penicillin-resistant (MICs of penicillin ranged from 0.25 µg/mL to 8 µg/mL). Te...
Saved in:
Published in: | Clinical infectious diseases Vol. 20; no. 5; pp. 1169 - 1173 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Chicago, IL
The University of Chicago Press
01-05-1995
University of Chicago Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We prospectively studied 260 episodes of bacteremia that occurred over a 6-year period in neutropenic patients with cancer. Twenty-three episodes were caused by viridans streptococci. Thirteen (57%) of these strains were penicillin-resistant (MICs of penicillin ranged from 0.25 µg/mL to 8 µg/mL). Ten of the 13 penicillin-resistant strains (77%) were highly resistant to penicillin (MIC, ⩾4 µg/mL). Rates of bacteremia due to highly penicillin-resistant viridans streptococci increased significantly from zero episodes per 1,000 admissions in 1987 to 17 episodes per 1,000 admissions in 1992 (P = .003). In a comparison between penicillin-resistant and penicillin-susceptible viridans streptococci bacteremia, the administration of β-lactam antibiotics during the previous 2 weeks was the only factor significantly associated with penicillin-resistant cases: 9 (69%) of 13 patients with penicillin-resistant bacteremia had received β-lactams vs. 2 (20%) of 10 patients with penicillin-susceptible bacteremia (P = .036). These findings may have significant clinical implications in the choice of both antimicrobial prophylaxis and empirical antibiotic regimens. |
---|---|
Bibliography: | istex:E9A9D17AF7AB16F3D4A0F416CD70B16B18F6EB8B ark:/67375/HXZ-HSSV6WNM-1 Reprints or correspondence: Dr. Jordi Carratalá, Infectious Disease Service, Hospital de Bellvitge, C/ Feixa Llarga s/n, 08907 L'Hospitalet, Barcelona, Spain. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 1058-4838 1537-6591 |
DOI: | 10.1093/clinids/20.5.1169 |